What would you like to do on
Pharma IQ today?
Upcoming
Webinars
Latest
Events
Become
a Member
Advertise
with Us

What would you like to do on Pharma IQ today?

Upcoming
Webinars
Latest
Events
Become
a Member
Advertise
with Us

LATEST CONTENT

Data Analytics in Life Sciences: Hottest Solutions & Investment Priorities  

How do I turn big data into smart data? How do I break down siloes? How do I implement the latest technologies? How do I utilise real world data?... Learn more »
November 25,2014 by IQPC 

Healthcare Apps 2015 Survey  

We want to understand more about your challenges, the app projects you are working on and solutions you are looking at so we can create an agenda... Learn more »
November 20,2014 by Pharma IQ Surveys 

Pharmaceutical Contract Manufacturing 2015 Survey  

We're asking for your experience and thoughts on the topic of contract manufacturing. Make your voice heard and be the first to hear the results!... Learn more »
November 18,2014 by Pharma IQ Surveys 

UPCOMING EVENTS

UPCOMING WEBINARS

  • RBC’s Epigenetics Toolbox: Enabling Epigenetic Research and Drug Discovery Watch now »
  • Translational Medicine Informatics - A Biopharma Case Study Watch now »
  • Product Inspection in the Packaging Industry - Are You Ready? Watch now »
  • How do You Maintain a Low Risk Global Supply of Drug Delivery Products in an Ever Changing and Uncertain World? Watch now »

LATEST WHITE PAPERS

Data Analytics in Life Sciences: Hottest Solutions & Investment Priorities  

How do I turn big data into smart data? How do I break down siloes? How do I implement the latest technologies? How do I utilise real world data? How do I analyse clinical trial data? These are the fundamental questions that life sciences professionals are asking about data analytics. We asked executives with control over data analytics spending to share what challenges their facing and what solutions their looking to invest in. Read more »
November 25,2014

50 Movers and Shakers in BioBusiness 2014  

As the global biobusiness sector undergoes rapid transformation, there are growing opportunities to tap. This report identifies 50 inspirational women in biobusiness in the UK who are challenging the status quo and bringing better health to people around the world. This report includes experienced leaders and rising stars. Read more »
November 17,2014

How to Determine Fair License Terms: No Need for Rules of Thumb Anymore  

An analogy between licensing and corporate investment facilitates the determination of fair license terms and displays whether the deal creates value for both parties. Clumsy and out of date rules of thumb are not needed anymore. Read more »
November 12,2014

LATEST INTERVIEWS

Vifor Pharma: Partnership Valuation in Pharma - What Really is a Good Deal?  

Dr. Roland Pfeiffer - Head Commercial Development Europe at Vifor Pharma Ltd. in Switzerland, takes a holistic perspective on analysing successful deals and how to prevent unsatisfactory deals. Read more »
November 11,2014 by Pharma IQ 

The View From Both Sides- Pharma and CRO Insights- An Interview with Eef Verhaegen  

Working closely and well with CROs is a real challenge in clinical trial supply and the success or failure of this relationship is a key factor in the success of a project. Pharma IQ spoke with Eef Verhaegen, Associate Director Global Clinical Supplies at PPD International about her views, having worked for both sides of the partnership. Eef also describes her keys to a successful relationship and explains the increasingly important challenge of ancillary supplies Read more »
November 06,2014 by Eef Verhaegen 

The Power of Community will Make Advancements in Predictive Toxicology - An Interview with Janssen’s David Gallacher  

Predictive Toxicology at any company doesn’t happen in a vacuum and the developments from regulators, rival companies and academia all effect how effectively the process occurs. Predictive toxicology faces common challenges and it is with a communal effort that they will be overcome; this is the view of David Gallacher, Senior Director Regulatory Affairs at Janssen Pharmaceuticals (J&J) in his interview with Pharma IQ. David also goes into detail about the assays and methodology being applied at Janssen Pharmaceuticals. Read more »
November 04,2014 by David Gallacher 

LATEST PODCASTS

Utilising Big Data for Bioscience Product Development  

Big data is turning up everywhere. In this Process Perspectives podcast, Kaare Buch Petersen, Information Architect in Global IT at Christen Hansen, a Denmark-based supplier of bioscience products to food and health industries, talks about how his company has been using big data in the development of their new products. Learn more »
July 03,2014

Fewer Robots, More Apps - An Interview with Jeff Hurst  

The informatics landscape is changing quickly and innovation could be the key to increasing efficiency. Jeff Hurst talks us through these changes and how the industry is moving away from robots towards more innovative methods including mobile apps. He also talks about the dangers of becoming overly 'enamoured with your data' and reinforces that the old rule Garbage in - Garbage Out still applies. Learn more »
March 25,2014

What Pharma can Learn from the Food & Beverage Industry- An Interview with Pepsico's Steve Hills  

The pharma industry has a lot to learn from the food and beverage industry when it comes to contract manufacturing. To get to grips with this outsider's view, we spoke with Steve Hills, European Contract Manufacturing Director at Pepsico. Steve outlines where companies can go wrong in working with CMOs Learn more »
March 13,2014

B2B Latest Events

Get the latest Pharma IQ news and Updates

Connect with your peers
Already a member? Sign In to complete your profile or Become a Member today!


Advertise With Us

Join the Pharmas IQ Community